Skip to main content

15 July 2025

Last updated: Thursday 10 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Innate Pharma's anti-cancer platform attracts BMS investment

Friday 15 July 2011

Interviewee/Contributor

Herve Brailly

Organisation

Innate Pharma SA

How Innate Pharma turned a threat into an opportunity

Monday 10 November 2008

Interviewee/Contributor

Herve Brailly

Organisation

Innate Pharma SA

Organisations

Merlin Biosciences Ltd
IP Group
Arecor Therapeutics Plc
Allergy Therapeutics Plc
Ablynx NV
Society for Family Health Nigeria
European Bioinformatics Institute
Innovation & International Relationship
ADC Therapeutics SA
Aduro Biotech Inc

Interviewees and Contributers

Oumeya Adjali
Désiré Collen
Alexa Machikas and Elena Kfoury
Erik Manting
Dr Matthew Wright
Chantal van Gils
Jennifer Cubino
Ralf Schmid and Emma Harvey
Bradley Bolzon
Keith Blundy

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Louise Peacock joins Aravax

Saturday 5 July 2025

Hans Menssen joins Priothera

Saturday 5 July 2025

Filippa Stenberg joins Mölnlycke Health Care

Saturday 5 July 2025

Commit Biologics appoints scientific advisory board

Saturday 5 July 2025

Cristina Csimma joins Asgard Therapeutics

Saturday 5 July 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form